1. Kvanta, Anders, Rangaswamy, Nalini, Holopigian, Karen, Stasi, Kalliopi, André, Helder. 2024. Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial. In Nature communications, 15, 7438. doi:10.1038/s41467-024-51575-4. https://pubmed.ncbi.nlm.nih.gov/39256350/
2. Choi, Vivian W, Bigelow, Chad E, McGee, Terri L, Police, Seshidhar R, Dryja, Thaddeus P. 2015. AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice. In Molecular therapy. Methods & clinical development, 2, 15022. doi:10.1038/mtm.2015.22. https://pubmed.ncbi.nlm.nih.gov/26199951/
3. Issa, Mohamad, Sukkarieh, Georges, Bruneau, Sebastien, Tadayoni, Ramin. 2024. A novel RLBP1 gene mutation associated to a flecked retina syndrome. In Retinal cases & brief reports, , . doi:10.1097/ICB.0000000000001574. https://pubmed.ncbi.nlm.nih.gov/38470931/
4. Ratnapriya, Rinki, Sosina, Olukayode A, Starostik, Margaret R, Chatterjee, Nilanjan, Swaroop, Anand. 2019. Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration. In Nature genetics, 51, 606-610. doi:10.1038/s41588-019-0351-9. https://pubmed.ncbi.nlm.nih.gov/30742112/
5. Damodar, Krishna, Dubois, Gregor, Guillou, Laurent, Brabet, Philippe, Kalatzis, Vasiliki. 2024. Dual CRALBP isoforms unveiled: iPSC-derived retinal modeling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 4319-4336. doi:10.1016/j.ymthe.2024.10.004. https://pubmed.ncbi.nlm.nih.gov/39385467/
智鼠故事 
